Related Experiment Video
Updated: Jul 6, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
The inhibin/activin family and ovarian cancer
1Prince Henry's Institute of Medical Research, Clayton, Victoria 3168, Australia.
Abstract:
Ovarian cancer is the most common fatal malignancy of the female reproductive tract and frequently presents at an advanced stage. There is, thus, a great need for more sensitive and accurate methods of diagnosis, including better tumor markers. A rapidly emerging technique is the application of assays for the inhibin peptide family in patients with various forms of ovarian cancer. Currently, in assays that detect molecules containing the inhibin a subunit, more than 80% of postmenopausal patients with mucinous epithelial ovarian tumors, and virtually all with granulosa-cell tumors, have elevated inhibin levels. The detection of activin in some tumor tissues suggests that this peptide may also prove to be of interest once satisfactory and specific assays for the circulating peptide are available. It is likely that significant progress will be made in this field within the next 5 years.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Intrinsic Apoptotic Pathway
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Inhibitors of Viral Protein Synthesis
Ovaries
On the ovarian surface, a layer of cuboidal...

